ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2018
Does the approach to economic evaluation in health care depend on culture, values, and institutional context?
Article in The European journal of health economics : HEPAC : health economics in prevention and care, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Adoption of the concept of person-centred care into discourse in Europe: a systematic literature review.Journal of health organization and management · 2021Pooled it
- Topic identification, selection, and prioritization for health technology assessment in selected countries: a mixed study design.Cost effectiveness and resource allocation : C/E · 2024Article
- Reconstructing the value puzzle in health technology assessment: a pragmatic review to determine which modelling methods can account for additional value elements.Frontiers in pharmacology · 2023Review
- Health Economic Aspects of Childhood Excess Weight: A Structured Review.Children (Basel, Switzerland) · 2022Review
- How Can We Optimize the Value Assessment and Appraisal of Orphan Drugs for Reimbursement Purposes? A Qualitative Interview Study Across European Countries.Frontiers in pharmacology · 2022Article
- Assessing the potential of HTA to inform resource allocation decisions in low-income settings: The case of Malawi.Frontiers in public health · 2022Article
- Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making.Cost effectiveness and resource allocation : C/E · 2021Article
- Should health technology assessment be more patient centric? If so, how?The European journal of health economics : HEPAC : health economics in prevention and care · 2020Article
- Regional differences in healthcare costs at the end of life: an observational study using Swiss insurance claims data.International journal of public health · 2020Observational
- The status of health economic evaluation within decision making in Austria.Wiener medizinische Wochenschrift (1946) · 2019Article
- Decision uncertainty and value of further research: a case-study in fenestrated endovascular aneurysm repair for complex abdominal aortic aneurysms.Cost effectiveness and resource allocation : C/E · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
29209854What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.